{"id":80,"date":"2018-07-31T11:31:03","date_gmt":"2018-07-31T09:31:03","guid":{"rendered":"https:\/\/www.kia-holding.com\/?page_id=80"},"modified":"2018-10-25T11:49:51","modified_gmt":"2018-10-25T09:49:51","slug":"beteiligung-gesundheit","status":"publish","type":"page","link":"https:\/\/www.kia-holding.com\/en\/aktivitaeten-weltweit\/beteiligung-gesundheit\/","title":{"rendered":"Health"},"content":{"rendered":"<p><strong>Geography:<\/strong> Business headquartered in German-speaking countries (DACH region)<\/p>\n<p><strong>Development status:<\/strong> Market-ready products, e.g. first sales, accepted prototypes and test customers, clinical trial data available<\/p>\n<p><strong>Sales potential:<\/strong> Reachable market &gt; 250 million euros worldwide, growth &gt; 5% p.a.; market and product advantages allow rapid sales growth: industrial size (&gt;10 million euros) achievable in five years; innovation-driven market with high potential customer benefits; customer demand already exists<\/p>\n<p><strong>Result potential:<\/strong> cash break-even promptly achievable, ideally in two to three years<\/p>\n<p><strong>Industry:<\/strong> Life sciences<\/p>\n<ul>\n<li>Medical technology<\/li>\n<li>Diagnostics<\/li>\n<li>Biotech\/Pharma (no drug development)<\/li>\n<li>Applied technologies<\/li>\n<li>We do not invest in research or development institutes<\/li>\n<\/ul>\n<p><strong>Management:<\/strong> Excellent staffing in terms of the product and technology side; other core functions adequately filled or, if required, promptly filled<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Geography: Business headquartered in German-speaking countries (DACH region) Development status: Market-ready products, e.g. first sales, accepted prototypes and test customers, clinical trial data available Sales potential: Reachable market &gt; 250 million euros worldwide, growth &gt; 5% p.a.; market and product advantages allow rapid sales growth: industrial size (&gt;10 million euros) achievable in five years; innovation-driven market with high potential customer benefits; customer demand already exists Result potential: cash break-even promptly achievable, ideally in two to three years Industry: Life sciences&hellip;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":11,"menu_order":40,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-80","page","type-page","status-publish","hentry"],"translation":{"provider":"WPGlobus","version":"3.0.2","language":"en","enabled_languages":["de","en","es","pt"],"languages":{"de":{"title":true,"content":true,"excerpt":false},"en":{"title":true,"content":true,"excerpt":false},"es":{"title":true,"content":true,"excerpt":false},"pt":{"title":true,"content":true,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/www.kia-holding.com\/en\/wp-json\/wp\/v2\/pages\/80","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.kia-holding.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.kia-holding.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.kia-holding.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.kia-holding.com\/en\/wp-json\/wp\/v2\/comments?post=80"}],"version-history":[{"count":7,"href":"https:\/\/www.kia-holding.com\/en\/wp-json\/wp\/v2\/pages\/80\/revisions"}],"predecessor-version":[{"id":262,"href":"https:\/\/www.kia-holding.com\/en\/wp-json\/wp\/v2\/pages\/80\/revisions\/262"}],"up":[{"embeddable":true,"href":"https:\/\/www.kia-holding.com\/en\/wp-json\/wp\/v2\/pages\/11"}],"wp:attachment":[{"href":"https:\/\/www.kia-holding.com\/en\/wp-json\/wp\/v2\/media?parent=80"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}